Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection—a single-center analysis including 132 patients
Authors:
- 18 December 1998
- journal article
- clinical trial
- Published by Wiley in International Journal of Cancer
- Vol. 79 (6) , 601-605
Abstract
Hepatocellular carcinoma (HCC) is one of the most severe sequelae of chronic liver disease. The only potentially curative therapeutic options are surgical resection and orthotopic liver transplantation. In most HCC patients, however, at clinical presentation the tumors are unresectable because of multicentricity or poor hepatic functional reserve due to pre-existing cirrhosis or not transplantable because of too advanced tumor stage or severe co-morbidity. In clinical practice, therefore, percutaneous ethanol injection (PEI) and transarterial chemoembolization (TACE) are widely used non-surgical therapeutic strategies. We prospectively analyzed the clinical factors determining the prognosis of 132 inoperable HCC patients and assessed the feasibility, therapeutic efficacy and safety of PEI, TACE and a combination thereof. Mean age of patients was 64 years; 95% of patients had liver cirrhosis and 39% were Okuda stage I, 48% stage II and 13% stage III. Fifteen patients were treated by PEI (group 1), 33 by TACE (group 2), 39 by TACE and PEI (group 3) and 45 received best supportive care (group 4). Survival correlated with the Child-Pugh class of liver cirrhosis and the Okuda stage of HCC. Favorable prognostic parameters were alpha-fetoprotein (AFP) levels p = 0.001). Patients with inoperable HCCs treated by the combination of TACE and PEI have a clear survival benefit. A favorable outcome can be expected in patients with compensated cirrhosis, a low Okuda stage, a baseline AFP level <100 ng/ml and absence of portal vein thrombosis. Int. J. Cancer (Pred. Oncol.) 79:601–605, 1998.Keywords
This publication has 20 references indexed in Scilit:
- Treatment of Hepatocellular CarcinomaHepatology, 1997
- Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization.Radiology, 1995
- A Comparison of Lipiodol Chemoembolization and Conservative Treatment for Unresectable Hepatocellular CarcinomaNew England Journal of Medicine, 1995
- Therapeutic effect of percutaneous ethanol injection on small hepatocellular carcinoma: evaluation with CT.Radiology, 1995
- Hepatocellular carcinoma after transcatheter hepatic arterial embolization. A histopathologic study of 84 resected casesCancer, 1994
- Natural History of Small Untreated Hepatocellular Carcinoma in Cirrhosis: A Multivariate Analysis of Prognostic Factors of Tumor Growth Rate and Patient SurvivalHepatology, 1992
- Neoplastic seeding complicating percutaneous ethanol injection for treatment of hepatocellular carcinoma.Radiology, 1992
- Hepatocellular Carcinoma in Italian Patients with CirrhosisNew England Journal of Medicine, 1991
- Prognosis of unresectable hepatocellular carcinoma: An evaluation based on multivariate analysis of 90 casesHepatology, 1991
- Morphological and biochemical effects of intrahepatic alcohol injection in the rabbitJournal of Gastroenterology and Hepatology, 1990